Carregant...
Efficient long-term depletion of CD20(+) B cells by rituximab does not affect gut-resident plasma cells
The vast majority of antibody-producing B cells are located within the gastrointestinal tract and are key players in maintaining homeostasis. The failure of rituximab, a potent B cell–depleting agent, to ameliorate ulcerative colitis in a single clinical trial has dampened enthusiasm to study B cell...
Guardat en:
| Publicat a: | Ann N Y Acad Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368409/ https://ncbi.nlm.nih.gov/pubmed/29291255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nyas.13577 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|